COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges
Review
[키워드] ACE
ACE2
acute respiratory syndrome
Angiotensin-converting enzyme
anti-rheumatic drug
Anti-rheumatic drugs
appear
arthralgia
Autoimmune disease
caused
challenge
clinical monitoring
coronavirus
coronavirus disease
COVID-19
cytokine
Cytokine storm
Diseases
Evidence
exacerbate
feature
Hyperactivation
immune response
Inflammation
knowledge
management
manifestation
mechanism
Musculoskeletal
myalgia
option
outcome
overlapping
pathway
Patient
patients
pro-inflammatory mediator
recommendation
resulting
Rheumatoid
rheumatoid arthritis
risk
risk of COVID-19
SARS-CoV-2
SARS-COV-2 infection
severity
Structure
therapeutic options
[DOI] 10.3390/cells10123291 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/cells10123291 PMC 바로가기 [Article Type] Review